3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- Submitting institution
-
The University of Liverpool
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 8554
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(17)30069-7
- Title of journal
- LANCET
- Article number
- -
- First page
- 1399
- Volume
- 389
- Issue
- 10077
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
192
- Research group(s)
-
C - Life Course and Chronic Diseases
- Citation count
- 195
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- JPHW made a significant contribution to the conception and design of the study, carrying out the study and analysis and interpretation of study data.
JPHW also contributed to the drafting and intellectual critique of the manuscript.
- Non-English
- No
- English abstract
- -
